Skip to main content

Table 3 The most common non-serious adverse events

From: A 6-month depot formulation of leuprolide acetate is safe and effective in daily clinical practice: a non-interventional prospective study in 1273 patients

Adverse event

Number of patients (%)*

Local reaction at injection site:

41 (3.2)

ā€ƒā€ƒā€ƒIrritation

21 (1.6)

ā€ƒā€ƒā€ƒNodule

7 (0.5)

ā€ƒā€ƒā€ƒPain

5 (0.4)

ā€ƒā€ƒā€ƒInduration

3 (0.2)

ā€ƒā€ƒā€ƒSwelling

2 (0.2)

ā€ƒā€ƒā€ƒBurning sensation

2 (0.2)

ā€ƒā€ƒā€ƒPruritus

1 (0.1)

ā€ƒā€ƒā€ƒHot flushes

15 (1.2)

  1. *Percentages are based on the total number of patients (n = 1273)